Brief: Sophia Genetics Expands Partnership With Astrazeneca To Include Multimodal Approaches For Cancer Drug Development
13/02/2023 11:11
Feb 13 (Reuters) - Sophia Genetics SA SOPH.O :
* SOPHIA GENETICS EXPANDS PARTNERSHIP WITH ASTRAZENECA TO INCLUDE MULTIMODAL
APPROACHES FOR CANCER DRUG DEVELOPMENT
Further company coverage: SOPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sophia Genetics SA
See all newsSwitzerland's SOPHiA GENETICS Q2 revenue rises on Liquid Biopsy growth
Brief: Sophia Genetics Enters Collaboration To Develop Companion Diagnostics For Precision Oncology Therapies
Sophia Genetics dips on $50 mln stock sale
Brief: Sophia Genetics Announces Pricing Of $50 Million Public Offering Of Ordinary Shares
Brief: Sophia Genetics Announces Proposed Public Offering Of Ordinary Shares